表紙
市場調查報告書
商品編碼
567968

蛋白質標識的全球市場

Protein Labeling Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

出版日期: | 出版商: Mordor Intelligence Pvt Ltd | 英文 95 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供蛋白質標識的全球市場調查,市場概要,各產品、用途、標識手法的市場趨勢及市場預測,市場促進、阻礙因素及市場機會分析,競爭情形,主要供應商簡介等總括性彙整。

第1章 簡介

第2章 摘要整理

第3章 主要推論

第4章 市場概要、產業趨勢

  • 市場概況
  • 波特的五力分析

第5章 市場動態

  • 促進因素
  • 阻礙因素
  • 市場機會

第6章 蛋白質標識的全球市場:各市場區隔

  • 各產品
    • 試劑、套件
    • 服務
    • 其他
  • 各用途
    • 免疫學的手法
    • 細胞化驗分析
    • 螢光顯微鏡
    • 蛋白質微陣列
    • 質譜分析
  • 各標識手法
    • 體外標識
    • 體內標識
    • 生物正交標識

第7章 蛋白質標識的全球市場:各地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 其他
  • 中東、非洲
    • 波灣合作理事會(GCC)
    • 南非
    • 其他
  • 南美
    • 巴西
    • 阿根廷
    • 其他

第8章 競爭情形

  • 合併、收購
  • 新產品的投入
  • 協定、合作、聯盟

第9章 主要供應商分析

  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • PerkinElmer, Inc.
  • F. Hoffman-La Roche AG
  • General Electric Company
  • Kaneka
  • Li-Cor, Inc.
  • New England Biolabs
  • Promega Corporation
  • SeraCare Life Sciences, Inc.
  • 其他企業

第10章 市場未來展望

目錄
Product Code: 51475

Proteins are the largest and most important biomolecules in a living organism, as they are vital to the functioning of an organism. Once they are formed within a cell, proteins interact with other biomolecules and carry out roles to keep the cell alive. Therefore, more importance is given to research the protein binding mechanism through specialized fields of studies, such as proteomics and protein chemistry.

Most of these techniques focus on the ability to specifically tag proteins by creating genetic fusions, and thereby, imparting distinctive properties for selective protein visualization, manipulation, and entrapment within complex biochemical environments. Various strategies are used to carry out successful protein labeling.

Key Market Trends

Fluorescence Microscopy is Expected to Dominate the Protein Labelling Market

A fluorescent tag, also known as a fluorescent label is a molecule that is attached chemically to aid in the detection of a biomolecule such as a protein, antibody, or amino acid. Fluorescent tagging, or labeling, uses a reactive derivative of a fluorescent molecule known as a fluorophore. The fluorophore selectively binds to a specific region or functional group on the target molecule and can be attached chemically or biologically.

Protein labeling is currently being widely utilized. Protein labeling uses a short tag to minimize disruption of protein folding and function. These fluorescent proteins can used in a broad range of applications including immunochemistry, fluorescence in situ hybridization (FISH), cell tracing, receptor labeling and fluorescence spectroscopy to name a few. Thus owing to the increasing applications the market for protein labeling is exepcted to grow further in the future as well.

North America is Expected to Dominate the Market

The North American countries of the United States (US) and Canada have a developed and well-structured health care system. These systems also encourage research and development.

Protein Labelling as a field of research is also growing in this region due to its increasing array of applications. These countries also have policies that favor such research. These policies encourage global players to enter the US and Canada. Therefore as a result, these countries enjoy the presence of many global market players. Furthermore the increasing adoption in personalized medicine and genomic sequencing is projected to contribute toward the region's growth in revenue throughout the forecast period.

Competitive Landscape

Majority of the protein labeling are being manufactured by the major key players. Market leaders with more funds for research and better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rise of awareness. This has also helped the market grow.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing R&D Expenditure for the Development of Protein Labeling
    • 4.2.2 Increasing Proteomics Research
  • 4.3 Market Restraints
    • 4.3.1 Lack of Skilled Professionals
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Reagents & Kits
    • 5.1.2 Services
    • 5.1.3 Other Products
  • 5.2 By Application
    • 5.2.1 Immunological Techniques
    • 5.2.2 Cell-based Assays
    • 5.2.3 Fluorescence Microscopy
    • 5.2.4 Protein Microarrays
    • 5.2.5 Mass Spectrometry
  • 5.3 By Labeling Method
    • 5.3.1 In-vitro Labeling
    • 5.3.2 In-vivo Labeling
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 General Electric Company
    • 6.1.2 Perkinelmer Inc
    • 6.1.3 Thermo Fisher Scientific Inc
    • 6.1.4 Merck & Co Inc
    • 6.1.5 F. Hoffmann-La Roche AG
    • 6.1.6 Kaneka Corporation
    • 6.1.7 Promega Corporation
    • 6.1.8 Li-Cor Inc
    • 6.1.9 New England Biolabs Inc
    • 6.1.10 SeraCare Life Sciences Inc

7 MARKET OPPORTUNITIES AND FUTURE TRENDS